Physician profile
Michael Sless
NPI 1801839709
$3,505.21
in general payments reported to CMS, 2019-2025
11 companies · $788 in 2025
The $788 reported for 2025 was more than what 87% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $917 · 2020: $221 · 2021: $128 · 2022: $317 · 2023: $581 · 2024: $553 · 2025: $788.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,921.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,248.32 | 2019-2025 | Total30, Dailies Total1 Multifocal, Precision7 |
| Tarsus Pharmaceuticals, INC. | $623.71 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $590.58 | 2022-2025 | Infuse, Miebo, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $425.95 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $221.16 | 2019-2025 | Acuvue |
| Coopervision INC. | $139.75 | 2019-2023 | Myday Contact Lens |
| Sun Pharmaceutical Industries INC. | $107.10 | 2022 | |
| Rxsight INC | $75.00 | 2025 | Rxsight Injector Handpiece, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Abb Con-Cise Optical Group LLC | $31.43 | 2019 | |
| Oyster Point Pharma, INC. | $21.67 | 2023 | Tyrvaya |
| Visioneering Technologies, INC. | $20.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sless listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.